227 related articles for article (PubMed ID: 14999737)
1. Solid-state characterization of mefenamic acid.
Panchagnula R; Sundaramurthy P; Pillai O; Agrawal S; Raj YA
J Pharm Sci; 2004 Apr; 93(4):1019-29. PubMed ID: 14999737
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of the thermal, spectroscopic and drug dissolution properties of mefenamic acid and polyoxyethylene-polyoxypropylene solid dispersions.
Andrews GP; Zhai H; Tipping S; Jones DS
J Pharm Sci; 2009 Dec; 98(12):4545-56. PubMed ID: 19399827
[TBL] [Abstract][Full Text] [Related]
3. Solid-state characterization of nevirapine.
Sarkar M; Perumal OP; Panchagnula R
Indian J Pharm Sci; 2008 Sep; 70(5):619-30. PubMed ID: 21394259
[TBL] [Abstract][Full Text] [Related]
4. Characterization of two polymorphs of salmeterol xinafoate crystallized from supercritical fluids.
Tong HH; Shekunov BY; York P; Chow AH
Pharm Res; 2001 Jun; 18(6):852-8. PubMed ID: 11474791
[TBL] [Abstract][Full Text] [Related]
5. Solid-state characterization and dissolution properties of Fluvastatin sodium salt hydrates.
Borgmann SH; Bernardi LS; Rauber GS; Oliveira PR; Campos CE; Monti G; Cuffini SL; Cardoso SG
Pharm Dev Technol; 2013; 18(2):525-34. PubMed ID: 23033850
[TBL] [Abstract][Full Text] [Related]
6. Characterization of two polymorphs of lornoxicam.
Zhang J; Tan X; Gao J; Fan W; Gao Y; Qian S
J Pharm Pharmacol; 2013 Jan; 65(1):44-52. PubMed ID: 23215687
[TBL] [Abstract][Full Text] [Related]
7. Solid-state characterization of rifampicin samples and its biopharmaceutic relevance.
Agrawal S; Ashokraj Y; Bharatam PV; Pillai O; Panchagnula R
Eur J Pharm Sci; 2004 Jun; 22(2-3):127-44. PubMed ID: 15158898
[TBL] [Abstract][Full Text] [Related]
8. Assessment of mefenamic acid polymorphs in commercial tablets using chemometric coupled to MIR and NIR spectroscopies. Prediction of dissolution performance.
Antonio M; Maggio RM
J Pharm Biomed Anal; 2018 Feb; 149():603-611. PubMed ID: 29202439
[TBL] [Abstract][Full Text] [Related]
9. Effect of melt sonocrystallization on pharmacotechnical properties of paracetamol, indomethacin and mefenamic acid characterized by dynamic laser scattering and its impact on solubility.
Kumar B; Sharma V; Pathak K
Drug Dev Ind Pharm; 2013 May; 39(5):687-95. PubMed ID: 22630048
[TBL] [Abstract][Full Text] [Related]
10. The solid-state characterization of fusidic acid.
Gilchrist SE; Letchford K; Burt HM
Int J Pharm; 2012 Jan; 422(1-2):245-53. PubMed ID: 22100514
[TBL] [Abstract][Full Text] [Related]
11. Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan.
Tran TT; Tran PH; Park JB; Lee BJ
Arch Pharm Res; 2012 Jul; 35(7):1223-30. PubMed ID: 22864745
[TBL] [Abstract][Full Text] [Related]
12. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
[TBL] [Abstract][Full Text] [Related]
13. Dissolution properties, solid-state transformation and polymorphic crystallization: progesterone case study.
Araya-Sibaja AM; Paulino AS; Rauber GS; Campos CE; Cardoso SG; Monti GA; Heredia V; Bianco I; Beltrano D; Cuffini SL
Pharm Dev Technol; 2014 Nov; 19(7):779-88. PubMed ID: 24032356
[TBL] [Abstract][Full Text] [Related]
14. Solubility behavior of polymorphs I and II of mefenamic acid in solvent mixtures.
Romero S; Escalera B; Bustamante P
Int J Pharm; 1999 Feb; 178(2):193-202. PubMed ID: 10205639
[TBL] [Abstract][Full Text] [Related]
15. Mefenamic acid anti-inflammatory drug: probing its polymorphs by vibrational (IR and Raman) and solid-state NMR spectroscopies.
Cunha VR; Izumi CM; Petersen PA; Magalhães A; Temperini ML; Petrilli HM; Constantino VR
J Phys Chem B; 2014 Apr; 118(16):4333-44. PubMed ID: 24654805
[TBL] [Abstract][Full Text] [Related]
16. Cryomilling-induced solid dispersion of poor glass forming/poorly water-soluble mefenamic acid with polyvinylpyrrolidone K12.
Kang N; Lee J; Choi JN; Mao C; Lee EH
Drug Dev Ind Pharm; 2015 Jun; 41(6):978-88. PubMed ID: 24849785
[TBL] [Abstract][Full Text] [Related]
17. Characterization of nicergoline polymorphs crystallized in several organic solvents.
Malaj L; Censi R; Capsoni D; Pellegrino L; Bini M; Ferrari S; Gobetto R; Massarotti V; Di Martino P
J Pharm Sci; 2011 Jul; 100(7):2610-22. PubMed ID: 21254066
[TBL] [Abstract][Full Text] [Related]
18. Effect of crystal habit on the dissolution behaviour of simvastatin crystals and its relationship to crystallization solvent properties.
Bukovec P; Benkic P; Smrkolj M; Vrecer F
Pharmazie; 2016 May; 71(5):263-8. PubMed ID: 27348970
[TBL] [Abstract][Full Text] [Related]
19. Multicomponent Crystal of Mefenamic Acid and N-Methyl-d-Glucamine: Crystal Structures and Dissolution Study.
Zaini E; Fitriani L; Sari RY; Rosaini H; Horikawa A; Uekusa H
J Pharm Sci; 2019 Jul; 108(7):2341-2348. PubMed ID: 30779887
[TBL] [Abstract][Full Text] [Related]
20. Characterization of tolbutamide polymorphs (Burger's forms II and IV) and polymorphic transition behavior.
Kimura K; Hirayama F; Uekama K
J Pharm Sci; 1999 Apr; 88(4):385-91. PubMed ID: 10187747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
